NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
DOW Turns to Training, Access to Drive GenAI.mil Adoption
With nearly 2 million users of the platform, DOW is using training and access to AI models to build familiarity with the tech.
2m read -
AI Reshapes Critical Infrastructure Cybersecurity
As AI accelerates cyber threats, critical infrastructure operators are embracing zero trust, automation and modernization to bolster their defenses.
38m watch Partner Content -
FEHRM CTO: TEFCA Could Take Federal Health Data Exchange to ‘Next Evolution’
FEHRM CTO Lance Scott discusses efforts to modernize and improve interoperability of electronic health records across the federal government.
7m watch -
Space Force Charts Shift to Warfighting Force for 2040
Officials outlined how new missions, resilient satellites, maneuver and AI are shaping the service’s future force.
3m read
